This is a routine, non-material sale by an officer; no immediate trading signal. Monitor for changes in volume or frequency, but current pattern suggests planned, periodic selling rather than a shift in sentiment.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 20 $30.07entry
- T+1 · 7mo ago −4.29%α −3.64% · $28.78
- T+5 · 7mo ago −10.24%α −11.16% · $26.99
- T+20 · 6mo ago −12.24%α −16.44% · $26.39
- T+60 · 4mo ago −9.18%α −15.96% · $27.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
David Rodman, an officer of Mineralys Therapeutics, filed a Form 144 notifying intent to sell 416 shares of common stock, acquired via exercise of employee stock options. This is a routine, small-scale transaction consistent with prior regular sales.
Key Facts
- Reporting person: David Rodman, Officer
- Number of shares proposed for sale: 416
- Nature of shares: Acquired through exercise of employee stock options
- Method: Broker-assisted cashless exercise
- Filing date: April 17, 2026
- Recent pattern: Part of ongoing, regular small sales, 13 similar transactions in the past 6 months
Financial Impact
Approximately $13,000 (based on 13,033.28 from prior transaction on 04/17/2026)
Risk Factors
- Minimal near-term selling pressure from this filing
- Potential perception of lack of confidence if pattern accelerates, though current pace is normal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000208 |
| Document: 0001964306-26-000208-index.html | 0001964306-26-000208 |
| Document: 0001964306-26-000208.txt | 0001964306-26-000208 |
Track record
35 reports on MLYS
4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.
Filters
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
- Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
- Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
- Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
- Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers